You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Litigation Details for Horizon Therapeutics Inc v. Par Pharmaceutical Inc (E.D. Tex. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Horizon Therapeutics Inc v. Par Pharmaceutical Inc
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for Horizon Therapeutics Inc v. Par Pharmaceutical Inc (E.D. Tex. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-04-23 1 United States Patent Nos. 8,404,215 (“the ’215 patent”) and 8,642,012 (“the ’012 patent”) (collectively… This is a civil action for patent infringement arising under the patent laws of the United States, …, FDA has listed United States Patent No. 5,968,979 (“the ’979 patent”), in connection with NDA No. 20…the United States Patent and Trademark Office duly and legally issued the ’215 patent, entitled “Methods…of the ’215 patent runs through March 9, 2032. A true and correct copy of the ’215 patent is attached External link to document
2015-10-20 129 in two asserted patents: U.S. Patent No. 8,404,215 (“the ’215 patent”) and U.S. Patent No. 8,642,012 (… for the disputed terms of U.S. Patent No. 8,404,215 and U.S. Patent No. 8,642,012. The parties are ORDERED…BACKGROUND AND THE ASSERTED PATENTS The ’215 patent and the ’012 patent describe methods for treating…ammonia level in the patent.” (’012 patent col. 42, ll. 60–62.) The ’012 patent defines the term “normal… enzymes or 1 The ’215 patent issued on March 26, 2013. The ’215 patent was filed on March 9, 2012 External link to document
2015-12-13 167 U.S. Patent No. 8,642,012 (the ’012 patent) and U.S. Patent No. 8,404,215 (the ’215 patent). Case 2… a stay. The Asserted Patents claim methods of using Ravicti (see ’215 patent col. 24, ll. 27–39) a… ORDER granting 151 Sealed Patent Motion. Signed by Magistrate Judge Roy S. Payne on 12/14/2015.…instituted IPR on all claims in the Asserted Patents.1 Par argues for a stay because the IPR decision…resolution of the [IPR] . . . of [the Asserted Patents] will not resolve all of, or even significantly External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.